title: [Osteoblastic differentiation of human adult mesenchymal stem cells after through gene transfer of BMP-2 in the absence of dexamethasone].
abstract: OBJECTIVE
  Mesenchymal stem cells (MSC) of various species appear to require different cues to differentiate towards the osteoblastic lineage. For MSC of human origin, recombinant hBMP-2 is reported to be not sufficient but dexamethasone seems to be essential. The aim of this study was to analyse changes in genotype and phenotype of hMSC after adenoviral transfer of the BMP-2 gene in the absence of dexamethasone.
  
  
  METHODS
  We employed hMSC and analysed changes in expression of the Runx2, Osterix and type I collagen gene by quantitative PCR after adenoviral transfer of the human BMP-2 gene in the absence of dexamethasone. As a phenotypic marker alkaline phosphatase activity was assessed. ANOVA and post hoc statistical analyses were used to determine differences among data (p < 0.05).
  
  
  RESULTS
  Transfer of the hBMP-2 gene and consecutive production of transgenic BMP-2 up-regulated bone marker gene expression and increased alkaline phosphatase activity and thus promoted an enhanced lineage progression to the osteoblast phenotype without the addition of dexamethasone.
  
  
  CONCLUSIONS
  These findings are noteworthy in the light of a possible superiority of endogenous transgenic proteins compared to exogenous recombinant proteins.
authors.affiliation: Klinik für Orthopädie und orthopädische Chirurgie, Universität Greifswald. hannjoer.koch@uni-greifswald.de
authors.forename: H
authors.initials: H
authors.lastname: Koch
authors.forename: J A
authors.initials: JA
authors.lastname: Jadlowiec
authors.forename: J D
authors.initials: JD
authors.lastname: Whalen
authors.forename: P
authors.initials: P
authors.lastname: Robbins
authors.forename: C
authors.initials: C
authors.lastname: Lattermann
authors.forename: F H
authors.initials: FH
authors.lastname: Fu
authors.forename: H R
authors.initials: HR
authors.lastname: Merk
authors.forename: J O
authors.initials: JO
authors.lastname: Hollinger
mesh_terms: D000328:Adult; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins / Q000235:genetics* / Q000378:metabolism*; D018929:Cell Culture Techniques / Q000379:methods; D002454:Cell Differentiation; D002478:Cells, Cultured; D003907:Dexamethasone; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology* / Q000378:metabolism*; D010006:Osteoblasts / Q000166:cytology* / Q000378:metabolism*; D010012:Osteogenesis / Q000502:physiology*; D011994:Recombinant Proteins / Q000378:metabolism; D023822:Tissue Engineering / Q000379:methods*; D014161:Transduction, Genetic / Q000379:methods*; D016212:Transforming Growth Factor beta / Q000235:genetics* / Q000378:metabolism*
chemical_list: C525718:BMP2 protein, human; D055396:Bone Morphogenetic Protein 2; D019485:Bone Morphogenetic Proteins; D011994:Recombinant Proteins; D016212:Transforming Growth Factor beta; D003907:Dexamethasone